CXCL8 and COVID-19: As calprotectin can regulate the production of TNF-α [106] and CXCL8 [108] and promote NF-κB activation [109], elevated levels of the S100A8/S100A9 heterodimer may trigger a harmful hyperinflammatory loop in patients with severe COVID-19.